Topic summary

What changed in 2026, by region

Access › International EMA NHS personal import Solved

This is a generated summary. It shows the 9 most-liked posts from a topic of 123, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

a.finnegan_rdTL2Dietitian26 Nov 2024#1

What changed in 2026, by region — that is the question, and I have not found it answered plainly anywhere I have looked.

Documenting an access outcome, dated, because everything in this category expires.

As of April 2026, in my region, the position is as described below. I have linked the primary source rather than a summary of it, because the summaries are consistently a year behind.

If anyone can confirm or contradict this for their own region, please date your answer. An undated claim in this category is worse than no claim.

52 likes 20mo

r.chukwuTL2 Moderator Solution4 Dec 2024#8

Coming back to post #6, because the follow-up matters more than the original answer.

Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more predictive than theory.

20 likes 20mo

ms_hollowayTL4Mass spectrometrist7 Dec 2024#12

This follows post #9 rather than contradicting it.

Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and coverage is necessary.

33 likes 20mo

s.coelhoTL2 Moderator10 Jan 2025#68

Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is unclear.

32 likes 19mo

b.friskTL2 Moderator12 Jan 2025#72

post #71 answers the question as asked. The question underneath it is different.

Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before ordering is prudent.

30 likes 18mo

c.okaforTL3Regular15 Jan 2025#79

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

31 likes 18mo

k.otieno_statsTL3Statistician26 Jan 2025#100

s.okonkwo, post #6: Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not eliminate) risk. Go to post

Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.

32 likes in reply to #6 18mo

b.oseiTL2 Moderator29 Jan 2025#108

footnote_entry, post #47: For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use. Go to post

Picking up post #105: that is the part I would want checked first.

Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.

30 likes in reply to #47 18mo

KnowltonTL3Regular2 Feb 2025#116

a.reyes, post #16: Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago. Go to post

Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not eliminate) risk.

32 likes in reply to #16 18mo

Read the full topic (123 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Language barriers in accessing a prescription abroad Access › International personal import telehealth EMA Solved Language barriers in accessing a prescription abroad Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…		2	22k	1h
Revisiting: Language barriers in accessing a prescription abroad Access › International EMA telehealth personal import MHRA Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Documenting an access outcome, dated, because everything…	+131	148	28k	5mo
Prescription portability between countries Access › International personal import MHRA telehealth EMA Wiki Prescription portability between countries — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…	+104	114	6.1k	3h
Second pass at: Cross-border purchase within the EU: the actual rules Access › International NHS personal import EMA telehealth Posting this under the heading it deserves: Second pass at: Cross-border purchase within the EU: the actual rules Everything below is what sits behind that. Documenting an access outcome, dated, because…	+135	139	8.7k	16mo
Cross-border purchase within the EU: the actual rules Access › International MHRA EMA telehealth NHS Solved Cross-border purchase within the EU: the actual rules Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is…	+6	10	41k	11mo

Related topics — sharing the tags EMA, NHS, personal import

Topic	Participants	Replies	Views	Activity
Cross-border purchase within the EU: the actual rules Access › International MHRA EMA telehealth NHS Solved Cross-border purchase within the EU: the actual rules Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is…	+6	10	41k	11mo
UK access routes, dated and sourced — a second dataset Regional › UK & Ireland MHRA NHS cost per milligram personal import Posting this under the heading it deserves: UK access routes, dated and sourced — a second dataset Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…	+76	82	25k	14mo
EMA product information as a primary source Regional › European Union personal import formulary EMA Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…	+70	74	7k	8mo
MHRA statements, read directly — the long version Regional › UK & Ireland MHRA cost per milligram personal import NHS On the subject in the title: MHRA statements, read directly — the long version Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of…		2	44k	22mo
EU-wide position versus national implementation — what changed since Regional › European Union EMA cost per milligram personal import formulary Pinned EU-wide position versus national implementation — what changed since Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included,…	+22	26	58k	2mo